ABBV
ABBVIE INC
Health Care·Biotechnology·UNITED STATES
$256.46
MCap $453.2B
as of 2026-09-04
Total
B9w
Fund
C4w
Quant
A9w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.57
Sentiment 83.0%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$256.46
Adaptive Mean
$259.40
-2.94 vs mean
Adaptive σ
2.56
MIDOS BB
$254.27 – $264.53
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+0.23
ROE
—
Z +1.75
Rev Gr
10.2%
Z -0.20
EPS Gr
290.4%
Z -0.08
OPM Gr
2.5%
Z -0.39
FCF Yld
3.7%
Z +0.38
EPS Surp
0.0%
Z -0.07
EPS 3mo Δ
106.7%
Z +0.19
Fwd P/E
15.75
Z —
PEGY
0.03
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
13.32
Q6M
6.01
Q12M
4.92
MA 30/100
1.094
Bullish (MA30 > MA100)
α (Jensen)
0.6279
β (12M)
-0.05
σ (12M)
0.265
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
81%
Q Percentile
79%
Divergence
+2.3
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
-2.7
RS Pctl
56%
RS Decile
D6
Persistence
9w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.